San Diego, CA · Founded 2024 · Privately Held (backing)
Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. Mirador Therapeutics is based in San Diego, CA and was founded in 2024. It was valued at $1 billion at its early-stage round in Jan 2026, the last priced event on record. It has raised $735 million across 2 recorded rounds; the latest was a $333 million later-stage round in Feb 2024.
PMV mark · valuation
$1.0B
Oct 2026
Priced at
its early-stage round
Jan 2026
Total raised
$735.0M
Last round
Later Stage VC
Feb 2024
No prints on record
No secondary trades in Mirador Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mirador Therapeutics with a free account
·The complete investor list: 17 names
·Watch Mirador Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Mirador Therapeutics stock.
